EPS for Teleflex Incorporated (TFX) Expected At $2.38

February 14, 2018 - By Linda Rogers

 EPS for Teleflex Incorporated (TFX) Expected At $2.38
Investors sentiment increased to 1.1 in Q3 2017. Its up 0.11, from 0.99 in 2017Q2. It increased, as 23 investors sold Teleflex Incorporated shares while 114 reduced holdings. 49 funds opened positions while 102 raised stakes. 39.29 million shares or 3.24% less from 40.61 million shares in 2017Q2 were reported.
Savings Bank Of Mellon Corporation stated it has 0.04% of its portfolio in Teleflex Incorporated (NYSE:TFX). Ls Inv Lc reported 5,012 shares. Gabelli Funds Ltd Liability, a New York-based fund reported 4,000 shares. Fairview Capital Investment Management Ltd Liability Corporation owns 3.01% invested in Teleflex Incorporated (NYSE:TFX) for 197,727 shares. Pnc Fincl Services Grp Incorporated accumulated 24,137 shares. Veritable Lp accumulated 4,940 shares or 0.03% of the stock. Brinker Capital has invested 0.02% of its portfolio in Teleflex Incorporated (NYSE:TFX). Zurcher Kantonalbank (Zurich Cantonalbank) owns 8,768 shares. Toronto Dominion Savings Bank holds 1,901 shares. Winfield Associate Inc has 5 shares. The New York-based Morgan Stanley has invested 0.01% in Teleflex Incorporated (NYSE:TFX). 5,702 are owned by M&T Bank. Goldman Sachs Group stated it has 369,536 shares or 0.02% of all its holdings. Livforsakringsbolaget Skandia Omsesidigt reported 0.02% of its portfolio in Teleflex Incorporated (NYSE:TFX). Mastrapasqua Asset reported 0.55% of its portfolio in Teleflex Incorporated (NYSE:TFX).

Since September 1, 2017, it had 0 insider buys, and 6 sales for $1.56 million activity. Klasko Stephen K. M.D. sold 200 shares worth $42,350.

Analysts expect Teleflex Incorporated (NYSE:TFX) to report $2.38 EPS on February, 22.They anticipate $0.25 EPS change or 11.74 % from last quarter’s $2.13 EPS. TFX’s profit would be $107.21 million giving it 26.78 P/E if the $2.38 EPS is correct. After having $2.12 EPS previously, Teleflex Incorporated’s analysts see 12.26 % EPS growth. The stock decreased 0.10% or $0.25 during the last trading session, reaching $254.95. About 170,277 shares traded. Teleflex Incorporated (NYSE:TFX) has risen 24.36% since February 14, 2017 and is uptrending. It has outperformed by 7.66% the S&P500.

Teleflex Incorporated (NYSE:TFX) Ratings Coverage

Among 11 analysts covering Teleflex (NYSE:TFX), 8 have Buy rating, 0 Sell and 3 Hold. Therefore 73% are positive. Teleflex had 32 analyst reports since July 31, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, September 5 by Jefferies. The stock of Teleflex Incorporated (NYSE:TFX) has “Hold” rating given on Tuesday, November 14 by Deutsche Bank. The rating was maintained by Jefferies on Thursday, November 2 with “Buy”. The rating was maintained by Brean Capital with “Buy” on Thursday, April 28. On Thursday, October 12 the stock rating was maintained by KeyBanc Capital Markets with “Hold”. Morgan Stanley maintained the shares of TFX in report on Friday, November 3 with “Equal-Weight” rating. Piper Jaffray initiated Teleflex Incorporated (NYSE:TFX) on Monday, November 30 with “Overweight” rating. Jefferies maintained Teleflex Incorporated (NYSE:TFX) rating on Tuesday, October 10. Jefferies has “Buy” rating and $270.0 target. As per Friday, January 6, the company rating was upgraded by Jefferies. The firm earned “Strong Buy” rating on Wednesday, January 6 by Raymond James.

Teleflex Incorporated designs, develops, makes, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company has market cap of $11.49 billion. It offers vascular access products consisting of Arrow branded catheters and related devices for critical care therapies, including the administration of intravenous medications and other therapies, the measurement of blood pressure, and withdrawal of blood samples; interventional access products that are used in dialysis, oncology, and critical care therapies; and anesthesia products, such as airway management products under the LMA and Rusch brands, and pain management products under the Arrow brand. It has a 46.6 P/E ratio. The firm also provides surgical products, such as ligating clips and fascial closure systems; bladeless access ports, sutures, and other surgical instruments; and single-use and reusable products for surgical procedures under the Deknatel, Pilling, Kmedic, Hem-o-lok, and Weck brands.

More recent Teleflex Incorporated (NYSE:TFX) news were published by: Businesswire.com which released: “Teleflex Announces US Launch of Two Next-Generation Versions of Its 0.035 …” on February 05, 2018. Also Businesswire.com published the news titled: “Teleflex Incorporated to Acquire NeoTract” on September 05, 2017. Businesswire.com‘s news article titled: “Teleflex Incorporated Completes Acquisition of NeoTract” with publication date: October 02, 2017 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: